Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2017-03-08 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
发行股份购买资产及重大资产出售暨关联交易报告书（草案）修订稿摘要
Capital/Financing Update Classification · 95% confidence The document is titled as a report on "发行股份购买资产及重大资产出售 暨关联交易报告书(草案)" which translates to "Issuance of Shares to Purchase Assets and Major Asset Sale and Related Party Transaction Report (Draft)". It contains detailed information about a major asset restructuring transaction including issuance of shares to purchase assets, major asset sale, related party transactions, valuation reports, transaction parties, share issuance details, lock-up arrangements, and impact on company control and shareholding structure. The document includes financial figures, valuation reports, and legal and financial advisor statements. This type of document is typical of a major asset restructuring or significant corporate transaction filing. It is not a simple announcement or a brief summary but a comprehensive report on a major transaction. According to the filing definitions, this fits best under "Capital/Financing Update (CAP)" as it involves issuance of shares to purchase assets, major asset sale, and related party transactions, all of which are financing and capital structure related updates. It is not an Annual Report, Interim Report, or Earnings Release. It is not a proxy or voting result announcement. It is not a merger proxy statement or tender offer form. It is a detailed transaction report related to capital issuance and asset purchase/sale. Therefore, the correct classification is CAP with high confidence.
2017-03-08 Chinese
2016年度备考审计报告
Audit Report / Information Classification · 95% confidence The document is titled as an audit report for the year 2016 of Chengdu Tianxing Instrument Co., Ltd. It contains detailed audited financial statements including a pro forma consolidated balance sheet, profit and loss statement, and extensive notes to the financial statements. The text includes the auditor's opinion, responsibilities, and detailed financial data for the fiscal year ending December 31, 2016. The presence of a formal auditor's opinion and comprehensive financial statements indicates this is a standalone audit report rather than a full annual report or other filing. The document length is substantial (15,000 characters), and it contains actual financial data and audit conclusions, not just an announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2016
2017-03-08 Chinese
北京贝瑞和康生物技术股份有限公司2016年度、2015年度、2014年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled as an audit report for Beijing Berry Genomics Co., Ltd. covering the fiscal years 2014, 2015, and 2016. It includes detailed financial statements such as consolidated and parent company balance sheets, income statements, cash flow statements, and notes to the financial statements. The text contains the auditor's opinion, responsibilities of management and auditors, and detailed financial data. The document length is substantial (15,000 characters) and contains the full audit report and financial statements, not just an announcement or certification. Therefore, this document fits the category of an Audit Report / Information (AR). FY 2016
2017-03-08 Chinese
发行股份购买资产及重大资产出售暨关联交易之反馈意见回复（一）
Capital/Financing Update Classification · 95% confidence The document is a detailed response to feedback regarding a transaction involving issuance of shares to purchase assets and a major asset sale, including related party transactions. It contains extensive financial data, analysis of business operations, shareholder structure, management changes, and valuation assessments. The presence of independent financial advisors, accountants, lawyers, and appraisers providing opinions indicates this is a comprehensive report related to a significant corporate transaction. The content aligns with disclosures typically found in filings related to capital transactions and major asset restructuring. Therefore, the document is best classified as a Capital/Financing Update (CAP).
2017-03-08 Chinese
发行股份购买资产及重大资产出售暨关联交易报告书（草案）修订稿
Capital/Financing Update Classification · 95% confidence The document is titled "发行股份购买资产及重大资产出售暨关联交易报告书" which translates to "Report on Issuance of Shares to Purchase Assets and Major Asset Disposal and Related Party Transactions." It details a major asset restructuring involving issuance of shares to purchase assets, major asset sales, related party transactions, valuation reports, financial impacts, shareholder structure changes, and approvals required. The document includes detailed financial data, transaction terms, and legal and financial advisor statements. This is a comprehensive report on a significant corporate transaction involving asset purchase and disposal, which fits the category of Capital/Financing Update (CAP) as it relates to financing activities and capital structure changes. It is not an announcement or a brief notice but a full report on the transaction. Therefore, the correct classification is CAP with high confidence.
2017-03-08 Chinese
中信建投证券股份有限公司关于公司发行股份购买资产及重大资产出售暨关联交易申请文件反馈意见回复
Capital/Financing Update Classification · 95% confidence The document is a detailed response to feedback on an application related to a company's issuance of shares to purchase assets and a major asset sale, including related party transactions. It contains extensive financial data, analysis of business operations, governance, shareholder structure, and legal compliance. The content focuses on a significant transaction involving asset acquisition and disposal, with detailed disclosures and independent professional opinions (financial advisors, lawyers, accountants). The document is not a general annual or quarterly report, nor is it a simple announcement or certification. It is a comprehensive filing related to a major asset restructuring transaction, which aligns with the category of Capital/Financing Update (CAP) as it involves issuance of shares for asset purchase and major asset sales. Therefore, the appropriate classification is CAP with high confidence.
2017-03-08 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.